| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |